289 related articles for article (PubMed ID: 17264038)
21. [Superficial grade G2 tumors of the bladder: recurrence, progression, prognosis].
Sebe P; Lebret T; Molinie V; Herve JM; Yonneau L; Lugagne PM; Saporta F; Orsoni JL; Butreau M; Botto H
Prog Urol; 2003 Sep; 13(4):608-12. PubMed ID: 14650291
[TBL] [Abstract][Full Text] [Related]
22. Comparison of flow cytometric DNA content analysis of fresh and formalin-fixed paraffin-embedded solid neoplasms.
Kumar D; Kumar S; Lyon D
Mod Pathol; 1994 Apr; 7(3):354-60. PubMed ID: 8058708
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic value of clinicopathologic factors in superficial bladder tumors: a retrospective analysis].
Rammeh-Rommani S; Zermani R; Zouari B; Sfaxi M; Chabchoub A; Farah F; Kourda N; Ayed M; Ben Jilani S
Tunis Med; 2005 Dec; 83(12):746-9. PubMed ID: 16450942
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric DNA and p53 analysis in superficially infiltrating bladder carcinoma.
Vatne V; Maartmann-Moe H; Hoestmark J
Anticancer Res; 1994; 14(6B):2735-8. PubMed ID: 7872710
[TBL] [Abstract][Full Text] [Related]
26. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
28. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini GP; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone WF; Bruzzi P
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1071-8. PubMed ID: 11045790
[TBL] [Abstract][Full Text] [Related]
31. [Impulse cytophotometry and irrigation cytology in the diagnosis of bladder cancer].
Maier G; Blech M; Droese M; Ringert RH
Urologe A; 1990 Nov; 29(6):330-3. PubMed ID: 2291258
[TBL] [Abstract][Full Text] [Related]
32. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
[TBL] [Abstract][Full Text] [Related]
33. A flow cytometric study on giant cell tumor of bone.
Guo W; Ren X; Feng C
Chin Med J (Engl); 1996 Feb; 109(2):134-7. PubMed ID: 8758338
[TBL] [Abstract][Full Text] [Related]
34. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
35. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
Wang Z
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
Michels JJ; Marnay J; Plancoulaine B; Chasle J
Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
[TBL] [Abstract][Full Text] [Related]
37. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors in bladder cancer].
Matveev BP; Bogatyrev VN; Ermilova VD; Figurin KM; Mustia AI; Iurasova IV; Ataev AA
Urol Nefrol (Mosk); 1994; (5):43-5. PubMed ID: 7871623
[TBL] [Abstract][Full Text] [Related]
39. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
Jakobsen A; Mommsen S; Olsen S
Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
[TBL] [Abstract][Full Text] [Related]
40. [DNA flow cytometry in the prognostication of certain malignant neoformations].
Nikolaeva TG; Dobrynin IaV; Akhundov AA; Prorokov VV; Davydov MI
Vopr Onkol; 2001; 47(6):684-9. PubMed ID: 11826489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
